The ‘apparent’ hydrolysis of alkyl esters during electrospray ionization
- 24 June 2003
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 17 (15) , 1703-1708
- https://doi.org/10.1002/rcm.1104
Abstract
Electrospray ionization (ESI) mass spectrometry was employed to obtain both molecular weight confirmation and structural information for a series of novel alkenyldiarylmethane (ADAM) analogs. The mass spectral data were intended for use during the structure elucidation of ester hydrolysis products formed during an in vitro metabolism study of a series of novel ADAM analogs. The data on the precursor molecules show the presence of the molecular ion peak, [M+H]+, as well as a peak consistent with the hydrolysis product of the original ester ([MH‐ROH+H2O]+). However, chemical ionization mass spectrometry, elemental analysis and 1H NMR data indicated the presence of only the intact diester compounds, suggesting that the formation of the hydrolysis product was an instrumental artifact, i.e., in‐beam hydrolysis during ESI or a result of longer ion residence times of the ion trap mass analyzer. Copyright © 2003 John Wiley & Sons, Ltd.Keywords
This publication has 33 references indexed in Scilit:
- The effect of water on the ion trap analysis of trimethylsilyl derivatives of long‐chain fatty acids and alcoholsRapid Communications in Mass Spectrometry, 2001
- Guide to Major Clinical Trials of Antiretroviral Therapy in Human Immunodeficiency Virus‐Infected Patients: Protease Inhibitors, Non‐Nucleoside Reverse Transcriptase Inhibitors, and Nucleotide Reverse Transcriptase InhibitorsClinical Infectious Diseases, 1999
- The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection1Presented at the Eleventh International Conference on Antiviral Research, San Diego, CA, 5–10 April 1998.1Antiviral Research, 1998
- New Alkenyldiarylmethanes with Enhanced Potencies as Anti-HIV Agents Which Act as Non-Nucleoside Reverse Transcriptase InhibitorsJournal of Medicinal Chemistry, 1998
- Antiretroviral therapy for patients with HIV diseaseBritish Journal of Clinical Pharmacology, 1998
- Synthesis and Biological Evaluation of Certain Alkenyldiarylmethanes as Anti-HIV-1 Agents Which Act as Non-Nucleoside Reverse Transcriptase InhibitorsJournal of Medicinal Chemistry, 1996
- Synthesis and biological evaluation of an alkenyldiarylmethane (ADAM) which acts as a novel non-nucleoside HIV-1 reverse transcriptase inhibitorBioorganic & Medicinal Chemistry Letters, 1995
- Toward Improved Anti-HIV Chemotherapy: Therapeutic Strategies for Intervention with HIV InfectionsJournal of Medicinal Chemistry, 1995
- Locations of Anti-AIDS Drug Binding Sites and Resistance Mutations in the Three-dimensional Structure of HIV-1 Reverse TranscriptaseJournal of Molecular Biology, 1994
- Design, Synthesis, and Biological Evaluation of Cosalane, a Novel Anti-HIV Agent Which Inhibits Multiple Features of Virus ReproductionJournal of Medicinal Chemistry, 1994